1. Home
  2. TLYS vs MAIA Comparison

TLYS vs MAIA Comparison

Compare TLYS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$1.69

Market Cap

51.2M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.76

Market Cap

49.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
MAIA
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.2M
49.3M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
TLYS
MAIA
Price
$1.69
$1.76
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$2.25
N/A
AVG Volume (30 Days)
83.1K
518.8K
Earning Date
12-03-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$545,742,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.87
52 Week High
$4.60
$2.74

Technical Indicators

Market Signals
Indicator
TLYS
MAIA
Relative Strength Index (RSI) 45.68 63.20
Support Level $1.58 $1.49
Resistance Level $1.86 $1.71
Average True Range (ATR) 0.14 0.14
MACD -0.04 0.01
Stochastic Oscillator 22.66 76.79

Price Performance

Historical Comparison
TLYS
MAIA

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: